Effect of abciximab on prothrombin activation and thrombin generation in patients with acute myocardial infarction also receiving reteplase


      Fibrinolysis in acute myocardial infarction activates blood coagulation and may favor reocclusion or ischemic complications. The aim of the GUSTO V Italian Hematologic Substudy was to compare the effects of full-dose reteplase on coagulation activation markers with those of half-dose reteplase combined with full-dose abciximab, a platelet glycoprotein IIb/IIIa receptor antagonist, during the early phase after acute myocardial infarction.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • The GUSTO Investigators
        Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition.
        Lancet. 2001; 57: 1905-1914
        • Merlini P.A.
        • Ardissino D.
        • Bauer K.A.
        • Oltrona L.
        • Spinola A.
        • Diotallevi P.
        • Rosenberg R.D.
        • Mannucci P.M.
        Activation of the hemostatic mechanism during thrombolysis in patients with unstable angina pectoris.
        Blood. 1995; 86: 3327-3332
        • Merlini P.A.
        • Bauer K.A.
        • Oltrona L.
        • Spinola A.
        • Cattaneo M.
        • Broccolino M.
        • Mannucci P.M.
        • Rosenberg R.D.
        Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction.
        J Am Coll Cardiol. 1995; 25: 203-209
        • Reverter J.C.
        • Beguin S.
        • Kassels H.
        • Kumar R.
        • Hhemker H.C.
        • Coller B.S.
        Inhibition of platelet mediated, tissue factor-induced thrombin generation by the mouse/chimeric 7E3 antibody.
        J Clin Invest. 1996; 98: 863-874
        • Gurbel P.A.
        • Serebruany V.L.
        • Shustov A.R.
        • Bahr R.D.
        • Carpo C.
        • Ohman E.M.
        Effect of reteplase and alteplese on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. GUSTO-III Investigators. Global Use of Strategies to Open Occluded Coronary Arteries.
        J Am Coll Cardiol. 1998; 31: 1466-1473